Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BADGER: Best Add-On Therapy for Childhood Asthma
NCT00395304Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Mar 2007
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate, salmeterol and montelukast in asthma (6 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Differential Response to Three Step-up Therapies at 16 weeks. Started Mar 2007; status: completed.
02
Drugs
fluticasone propionatesalmeterolmontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00395304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395304.